| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/03/2013 | CN103012576A C-reactive protein as well as preparation and application thereof |
| 04/03/2013 | CN103012566A Non-phosphorylation ligand combined with Grb7 protein SH2 structural domain and pharmaceutical application thereof |
| 04/03/2013 | CN103012561A Small peptide for tumor targeted diagnosis |
| 04/03/2013 | CN103012559A Peptaibol compound and application thereof |
| 04/03/2013 | CN103012558A Cation symmetrical amphipathic self-assembled polypeptide and application thereof |
| 04/03/2013 | CN103012557A Caffeoyl-alpha-neoendorphin peptide derivative and use thereof as an anti-itch and anti-atopic material |
| 04/03/2013 | CN103012555A Preparation method for new polypeptide having tissue protection activity, and application of new polypeptide in treatment |
| 04/03/2013 | CN103012554A Hydrocortisone-RGD polypeptide conjugate, and preparation method and application thereof |
| 04/03/2013 | CN103012553A Cortisone-RGD polypeptide conjugate, and preparation method and application thereof |
| 04/03/2013 | CN103012552A Bioactive polypeptide QEPV, and preparation and application thereof |
| 04/03/2013 | CN103007296A Mould for intervention of liraglutide in GK rat and application thereof in intervention treatment diabetes B medicine |
| 04/03/2013 | CN103007260A Preparation method of medicine for rapidly healing burned tissue |
| 04/03/2013 | CN103007259A Bromelain capsule for burn wound repair debridement and preparation method of same |
| 04/03/2013 | CN103007258A Medical composition containing fish serine protease and antibacterial compound, and uses thereof |
| 04/03/2013 | CN103007257A Foot care embathing liquid containing marine organism degerming component and preparation method of foot care embathing liquid |
| 04/03/2013 | CN103007256A Hair growth preparation |
| 04/03/2013 | CN103007255A Application of liraglutide to preparation of drugs for treating bone lesions caused by type 2 diabetes mellitus |
| 04/03/2013 | CN103007254A Application of glucagon-like peptide-1 in preparing medicament for treating 1-type diabetes mellitus |
| 04/03/2013 | CN103007253A Pharmaceutical composition containing beta-galactosylation azo ene glycol and preparation method thereof |
| 04/03/2013 | CN103007252A Antioxidation health care product and preparation method thereof |
| 04/03/2013 | CN103007251A Drug for treating herpes viruses and preparation method thereof |
| 04/03/2013 | CN103007250A Bovine blood polypeptide preparation and preparation method thereof |
| 04/03/2013 | CN103006612A Lisinopril controlled-release tablet and preparation method thereof |
| 04/03/2013 | CN103006562A Daptomycin ethosome preparation |
| 04/03/2013 | CN103006540A Stable pharmaceutical composition containing factor VIII |
| 04/03/2013 | CN103005466A Application for drone pupae polypeptide extract |
| 04/03/2013 | CN103005462A Composition for preventing and improving metabolic syndrome |
| 04/03/2013 | CN102370612B Chitosan-monomethoxy polyethylene glycol gel delivery system and preparation method thereof |
| 04/03/2013 | CN102274182B Multivesicular liposome containing exenatide, preparation method and application thereof |
| 04/03/2013 | CN102268079B (Classical swine fever virus) CSFV E2 protein ligand epitope peptide and application thereof |
| 04/03/2013 | CN102174097B Actinoporin and application thereof |
| 04/03/2013 | CN102108351B Low-immunogenicity staphylokinase mutant and preparation method and use thereof |
| 04/03/2013 | CN102107008B DNA damage repair inhibitors for treatment of cancer |
| 04/03/2013 | CN102093440B Coproduction process of pig brain protein hydrolysate and monosialoganglioside |
| 04/03/2013 | CN102091326B Transdermal medicament delivery preparation for treating hemorrhoid diseases caused by expansion or varix of anal subcutaneous veniplex and preparation method thereof |
| 04/03/2013 | CN102091325B Enzymic digestion hemorrhoids ointment and method for preparing same from potato |
| 04/03/2013 | CN101899100B Anti-HIV-I (Human Immunodeficiency Virus-I) polypeptides as well as coding sequences and applications thereof |
| 04/03/2013 | CN101775429B Whey protein antioxidant peptides, preparation method thereof and application thereof |
| 04/03/2013 | CN101687007B Composition for prevention and/or treatment of peptic ulcer |
| 04/03/2013 | CN101631555B Prophylactic agent for autoimmune disease |
| 04/03/2013 | CN101496815B Medicament for treating hepatic failure and preparation method thereof |
| 04/03/2013 | CN101426517B Pharmaceutical composition containing GHRP-6 capable of preventing and eliminating fibrosis and other forms of pathological deposit in tissue |
| 04/03/2013 | CN101365473B Pharmaceutical composition for treating or preventing ovarian cancer |
| 04/03/2013 | CN101313063B Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen |
| 04/03/2013 | CN101268093B Age抑制剂 Age Inhibitor |
| 04/03/2013 | CN101257916B 黑皮质素受体配体 Melanocortin receptor ligands |
| 04/03/2013 | CN101027099B Diagnostic marker for cancer |
| 04/02/2013 | US8410253 Scavenger receptor |
| 04/02/2013 | US8410252 ULBP2 polypeptides |
| 04/02/2013 | US8410246 TDF-related compounds and analogs thereof |
| 04/02/2013 | US8410148 Method and composition for potentiating an opiate analgesic |
| 04/02/2013 | US8410082 Fluorinated diaryl urea derivatives |
| 04/02/2013 | US8410074 Modulation of eIF4E expression |
| 04/02/2013 | US8410062 Collagen peptide, dipeptide and malady inhibitor |
| 04/02/2013 | US8410061 Variants of hedgehog protein that contain N-terminal modifications are described that can block hedgehog function; thus allowing these variants to serve as functional antagonists. These peptides have a primary amino acid sequence |
| 04/02/2013 | US8410060 Soluble tumor necrosis factor receptor treatment of medical disorders |
| 04/02/2013 | US8410059 CXCR4 antagonist and use thereof |
| 04/02/2013 | US8410057 Method of inducing T cell apoptosis by administering Altered Peptide Ligand |
| 04/02/2013 | US8410055 Skin wound healing compositions and methods of use thereof |
| 04/02/2013 | US8410054 Methods for treating pain by inhibition of the SCN9A channel |
| 04/02/2013 | US8410053 Methods for treating autoimmune disorders, and reagents related thereto |
| 04/02/2013 | US8410052 Oral administration of a calcitonin |
| 04/02/2013 | US8410051 FGF21 mutants and uses thereof |
| 04/02/2013 | US8410050 Method for achieving desired glial growth factor 2 plasma levels |
| 04/02/2013 | US8410049 Methods and kits for preventing hypoglycemia |
| 04/02/2013 | US8410048 Method for producing insulin analogs having a dibasic B chain terminus |
| 04/02/2013 | US8410047 Counteracting drug-induced obesity using GLP-1 agonists |
| 04/02/2013 | US8410046 Antibiotic peptide derived from ribosomal protein L1 of Helicobacter pylori and use thereof |
| 04/02/2013 | US8410045 Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
| 04/02/2013 | US8410044 Bacitracin antibiotics |
| 04/02/2013 | US8410043 Stabilized activin IIB receptor polypeptides and uses thereof |
| 04/02/2013 | US8409858 Modular functional peptides for the intracellular delivery of nanoparticles |
| 04/02/2013 | US8409840 Recombinant preparation of selected bromelain fractions |
| 04/02/2013 | US8409817 Methods and compositions for detection of Ehrlichia chaffeensis (VLPT) |
| 04/02/2013 | US8409810 Platelet aggregation assays using a CD40L-binding agent |
| 04/02/2013 | US8409641 Engineering enzymatically susceptible phytases |
| 04/02/2013 | US8409625 Conditioned decellularized native tissues for tissue restoration |
| 04/02/2013 | US8409622 Process for manufacturing biocompatible material |
| 04/02/2013 | US8409605 Biocompatible material composition adaptable to diverse therapeutic indications |
| 04/02/2013 | US8409591 Methods and compositions for the dietary management of autoimmune disorders |
| 04/02/2013 | US8409586 Stable liquid formulation of human growth hormone |
| 04/02/2013 | US8409584 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 04/02/2013 | US8409582 Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods |
| 04/02/2013 | US8409581 Compounds for treating amyloidoses |
| 04/02/2013 | US8409580 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
| 04/02/2013 | US8409578 Methods for treating bone loss with antibodies to OPGL |
| 04/02/2013 | US8409575 Antibodies specific for amyloid beta protofibril |
| 04/02/2013 | US8409569 Compositions and methods for diagnosing and treating an inflammation |
| 04/02/2013 | US8409566 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 04/02/2013 | US8409565 Therapeutic target and diagnostic marker for asthma and related conditions |
| 04/02/2013 | US8409562 Chimeric vaccine antigens against classical swine fever virus |
| 04/02/2013 | US8409560 Solid dispersion formulations and methods of use thereof |
| 04/02/2013 | US8409548 Administration of growth factors for the treatment of CNS disorders |
| 04/02/2013 | CA2681317C A synthetic peptide containing bone forming peptide 1(bfp 1) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide |
| 04/02/2013 | CA2623635C Compositions and methods of using chondroitinase abci mutants |
| 04/02/2013 | CA2582974C Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods |
| 04/02/2013 | CA2581110C Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions |
| 04/02/2013 | CA2556805C Use of factor xiii for stimulating the perfusion of ischemic tissue |
| 04/02/2013 | CA2555792C Therapeutic administration of the scrambled anti-angiogenic peptide c16y |
| 04/02/2013 | CA2546498C Peptide increasing fusiogenic capacity of a gamete |